Nadecnemab | Interleukin Related interleukin-related.com

Product Name :
Nadecnemab

Search keywords :
Nadecnemab

drugId :
null

Target Vo:
GDNF family receptor alpha-3

Target Vo Short Name :
GFR-Alpha-3

Moa_Name:
GDNF family receptor alpha-3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Regeneron Pharmaceuticals Inc

Active Company_Name :
Regeneron Pharmaceuticals Inc

Active Indication_Name:

In Active Indication_Name:
Pain

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MRC1 Antibody site
BTK (YP5017) Mouse mAb medchemexpress
LRP6 Antibody: LRP6 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 180 kDa, targeting to LRP6. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts